On June 20, the U.S. Food and Drug Administration (FDA) approved Sivextro (tedizolid phosphate) to treat patients with acute bacterial skin and skin structure infections caused by certain susceptible bacteria, including Staphylococcus aureus. Read more.
FDA approves new drug for serious skin infections
Most Recent Content
For Nurse Practitioners
Do Vitamins, Plants Help Uterine Fibroid Risk or Treatment?
A research team out of Poland recently undertook a comprehensive examination of published data to determine the role that vitamins and diet might play...
